Brief: Active Biotech appoints Helen Tuvesson as new CEO
19/06/2017 14:30
June 19 (Reuters) - Active Biotech Ab ACTI.ST
* the Board has appointed the company's current CSO Helén
Tuvesson as new CEO of Active Biotech AB
* Tuvesson will take up the position on July 1
* Tomas Leanderson, CEO since 2008, will be at the
company's disposal during a transitional period
Source text for Eikon: ID:nGNE5QTqwD
Further company coverage: ACTI.ST
(Reporting By Anna Ringstrom)
((Anna.Ringstrom@thomsonreuters.com;))